EUVIMEDPoznaj EUVIMED
Open access

ISOT Position Statement on Immunological Evaluation in Kidney Transplantation

Manish R Balwani, Anil Kumar, Vivek B Kute, Khushboo Saxena, Pranjal Kashiv, Jigar Shrimali, Subho Banerjee, Divyesh P Engineer, Sanjay Kumar Agarwal, Sanjay Kolte, Amit Pasari, Feroz Aziz and 24 more

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70631 ↗

At a glance

Journal article in Clinical Transplantation, 2026. Written by Manish R Balwani and 35 co-authors. Institution: Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India. Major MEDLINE topics: Kidney Transplantation, Histocompatibility Testing, Practice Guidelines as Topic, Graft Rejection. 63 references. The full text is freely available in PubMed Central.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Background

Immunological evaluation plays a central role in kidney transplantation, guiding donor selection, risk assessment, and graft outcomes. Although international guidelines are comprehensive, applying them in a real‐world low resource setting can be challenging where laboratory capacity varies and access to advanced testing is limited. There is therefore a need for implementable guidelines that reflect local realities while maintaining clinical rigor.

Methods

The Indian Society of Organ Transplantation (ISOT) brought together a multidisciplinary panel of transplant nephrologists, surgeons, clinical immunologists, and histocompatibility laboratory scientists from centers across India. A focused review of international guidelines, systematic reviews, and key studies was undertaken. Draft recommendations were developed and shared ahead of a structured consensus meeting. These were discussed, refined, and finalized through iterative expert deliberation. Recommendations were classified as “Recommended” or “Suggested” based on consensus, and their evidentiary basis was clearly defined.

Results

A total of 48 consensus recommendations were developed across 13 thematic areas covering key aspects of immunological evaluation. These included immunological risk assessment, antibody screening and crossmatch testing including virtual crossmatch, sensitization assessment, serum sampling and waitlist monitoring, HLA typing, post‐transplant monitoring, laboratory governance and immunological assessment in ABO‐incompatible transplantation. Of these, 23 were “Recommended” and 25 “Suggested.” Additional guidance focused on resource‐adapted and cost‐conscious approaches suited to the Indian context.

Conclusions

These recommendations offer a practical and standardized framework for immunological evaluation in kidney transplantation within low‐ and middle‐income settings. Their adoption has the potential to improve patient safety and optimize graft outcomes.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationHistocompatibility TestingPractice Guidelines as TopicGraft RejectionHumansGraft SurvivalHLA AntigensPrognosis

Author keywords

HLAantibodiesblood group incompatibilitycrossmatchingdesensitizationhistocompatibility testingimmunologickidney transplantation

Substances

HLA Antigens

Authors and institutions

  • Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India.
  • Department of Nephrology, Jawaharlal Nehru Medical College, DMIHER, Wardha, Maharashtra, India.
  • National Organ and Tissue Transplant Organization (NOTTO), Ministry of Health and Family Welfare, Government of India, New Delhi, India.
  • Treasurer, Indian Society of Organ Transplantation, Ahmedabad, Gujarat, India.
  • Department of Nephrology, Institute of Kidney Diseases and Research Center and Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India.
  • Department of Nephrology, Renus Kidney Hospital, Ahmedabad, Gujarat, India.

Cite

APA

Balwani, M. R., Kumar, A., Kute, V. B., Saxena, K., Kashiv, P., Shrimali, J., Banerjee, S., Engineer, D. P., Agarwal, S. K., Kolte, S., Pasari, A., Aziz, F., Das, P., Hegde, U., Ray, D. S., Agarwal, D., Sharma, S., Bhawane, A., Prasad, N., …, & Meshram, H. S. (2026). ISOT Position Statement on Immunological Evaluation in Kidney Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70631

Vancouver

Balwani MR, Kumar A, Kute VB, Saxena K, Kashiv P, Shrimali J, et al. ISOT Position Statement on Immunological Evaluation in Kidney Transplantation. Clinical Transplantation. 2026. doi:10.1111/ctr.70631

BibTeX
@article{Balwani2026,
  author = {Balwani, Manish R and Kumar, Anil and Kute, Vivek B and Saxena, Khushboo and Kashiv, Pranjal and Shrimali, Jigar and Banerjee, Subho and Engineer, Divyesh P and Agarwal, Sanjay Kumar and Kolte, Sanjay and Pasari, Amit and Aziz, Feroz and Das, Pratik and Hegde, Umapati and Ray, Deepak S and Agarwal, Dhananjai and Sharma, Sourabh and Bhawane, Amol and Prasad, Narayan and Chaudhury, Arpita Ray and Raju, Sreebhushan and Tapiawala, Shruti and Jain, Vikas and Das, Debasis and Deshpande, Vrushali and Ramteke, Vishal and Sharma, Ashish and Bhalla, Anil K and Guleria, Sandeep and Abraham, Georgi and Parmar, Vishal and Selvakumar, Sakthi and Godara, Suraj M and Gothwal, Kapil and Chauhan, Sanshriti and Meshram, Hari Shankar},
  title = {ISOT Position Statement on Immunological Evaluation in Kidney Transplantation},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70631}
}
Start for free →